No results displayed.
Inside "Interviews with Patients and Researchers":
@CancerQuest on Twitter:
Related to this page:
Was this page helpful?
|
Page 34 of 45 | <Previous : Next> Jump to Page:

Interview with Dr. Bill Nelson

Dr. Bill Nelson
Professor, Departments of Oncology, Urology, Pharmacology and Molecular Sciences, Medicine, Pathology, and Radiation Oncology and Molecular Radiation Sciences
John's Hopkins School of Medicine

Dr. Nelson's research focuses on epigenetic changes in prostate cancer. Epigenetics deals with changes that affect the activity of a gene without changing the DNA sequence of the gene.  The changes include DNA methylation and histone acetylation.  Dr. Nelson also investigates how these changes can be targeted by cancer drugs.

Image of Dr. Bill Nelson

Questions and Answers

About Dr. Nelson(Time: 9 sec)
How did you first become interested in research, specifically cancer research?(Time: 2 min 38 sec)
What is cancer epigenetics?(Time: 45 sec)
What is the focus of your current research?(Time: 36 sec)
How does epigenetic research differ from more common cancer research found in journals?(Time: 1 min 26 sec)
What are some recent findings in epigenetic cancer research?(Time: 3 min 57 sec)
What are the advantages and disadvantages of epigenetic cancer treatments?(Time: 3 min 1 sec)
Do you involve students in your research?(Time: 2 min 19 sec)
Are you involved in teaching in the classroom?(Time: 1 min 5 sec)
What cancers are being treated currently with epigenetic drugs?(Time: 49 sec)
What do you see for the future of cancer epigenetics?(Time: 2 min 37 sec)
Page 34 of 45 | <Previous : Next>
Last Modified: 10/08/2010 Print Email Page Share
Copyright ©2012 Emory University. All rights reserved.
Direct questions and comments to cancerquest@emory.edu.
Disclaimer | Legal Policies | Contact
Follow @CancerQuest on Twitter
CancerQuest Dictionary
Follow us on: